$LOGC News

Last published 2d ago

2d agoLOGCContextLogic Holdings Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
2d agoLOGCContextLogic Holdings Inc. Reports Third-Quarter 2026 Financial ResultsGlobeNewswireOAKLAND, Calif., Nov. 09, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the
2mo agoLOGCContextLogic Holdings Inc. Publishes Q&A Following Second Quarter 2026 ResultsGlobeNewswireOAKLAND, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today published a Q&A document to its
3mo agoLOGCContextLogic Holdings Inc. Reports Second-Quarter 2026 Financial ResultsGlobeNewswireOAKLAND, Calif., Aug. 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the
3mo agoWISH LOGCContextLogic Investor Call - CONTEXTLOGIC INCEarnings Call TranscriptsGood morning, ladies and gentlemen, and thank you for standing by. Welcome to today's call announcing the acquisition of GCAM, Gaylord Chemical Company, by ContextLogic. At this time, all participants are in a listen-onl
3mo agoLOGCContextLogic to Acquire gChem for $850 MillionGlobeNewswiregChem will become ContextLogic's second operating business, following the acquisition of US Salt in February 2026gChem is a sixty-four-year-old, vertically-integrated specialty chemicals company whose products serve
4mo agoLOGCContextLogic Appoints Seth Siegel as Senior AdvisorGlobeNewswireOAKLAND, Calif., July 13, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our"), a business ownership platform focused on
5mo agoCTLP LOGCContextLogic Holdings Inc. Announces Scott Stewart as Chief Financial Officer & Chief Operating OfficerGlobeNewswireOAKLAND, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings, Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") announced the appointment of Scott Stewart as its Chief Financial Officer and
5mo agoLOGCContextLogic Holdings Inc. Publishes Q&A Following First Quarter 2026 ResultsGlobeNewswireOAKLAND, Calif., May 22, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today published a Q&A document to its website following the release of its
6mo agoLOGCContextLogic Holdings Inc. Reports First-Quarter 2026 Financial ResultsGlobeNewswireOAKLAND, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the first quarter ended March 31, 2026.
7mo agoLOGCContextLogic Appoints Paul S. Levy to Board of DirectorsGlobeNewswireOAKLAND, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our"), a business ownership platform focused on acquiring and building a portfolio of
8mo agoLOGCContextLogic Holdings Inc. Reports Fourth-Quarter and Fiscal Year 2025 Financial ResultsGlobeNewswireOAKLAND, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the fourth quarter and fiscal year
8mo agoLOGCContextLogic Completes $907.5 Million Acquisition of US Salt, Marking Transformation into Business Ownership PlatformGlobeNewswireOAKLAND, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today announced the successful completion of its acquisition of US Salt Parent
9mo agoLOGCContextLogic Advances US Salt Acquisition with Launch of Fully Backstopped $115 Million Rights Offering Priced at $8.00 per shareGlobeNewswireOAKLAND, Calif., Jan. 22, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today announced the launch of a fully
11mo agoLOGCContextLogic to Acquire US Salt from Emerald Lake in $907.5 Million Transaction, Creating New Business Ownership Platform in Partnership with Abrams Capital and BC Partners CreditGlobeNewswireMarks the first step in building ContextLogic into a differentiated business ownership platform. ContextLogic will be focused on owning niche, competitively-advantaged, long-duration businesses run by world-class
1y agoLOGCContextLogic Holdings Inc. Reports Third-Quarter 2025 Financial ResultsGlobeNewswireOAKLAND, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and nine months ended
1y agoLOGCContextLogic to Announce Third Quarter 2025 Results on October 28, 2025GlobeNewswireOAKLAND, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC), ("ContextLogic" or the "Company") today announced it will report its third quarter 2025 financial results after the close of
1y agoLOGCContextLogic Holdings Inc. Reports Second-Quarter 2025 Financial ResultsGlobeNewswireOAKLAND, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and six months ended June
1y agoLOGCContextLogic Holdings Completes Corporate ReorganizationGlobeNewswireOAKLAND, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC), a Delaware corporation ("ContextLogic Holdings," the "Company," "we" or "our") today announced the completion of its plan of
1y agoLOGCContextLogic to Announce Second Quarter 2025 Results on August 7, 2025GlobeNewswireOAKLAND, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (OTCQB:LOGC), ("ContextLogic" or the "Company") today announced it will report its second quarter 2025 financial results after the close of market on
1y agoDMRC LOGC MOBL SREVRishi Bajaj, Founder and CIO of Altai Capital Management and CEO of ContextLogic Inc., Joins Digimarc's Board of DirectorsBusiness WireBajaj brings broad financial and strategic experience to Digimarc Board as the company builds the trust layer for the modern world. Digimarc Corporation (NASDAQ:DMRC), a pioneer in digital watermarking technologies,
1y agoLOGCContextLogic Urges ALL Stockholders to Protect the Value of their Investment by Voting "FOR" the Reorganization TODAYGlobeNewswireOAKLAND, Calif., July 17, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today reminds stockholders to vote "FOR" the proposed reorganization plan (the
1y agoLOGCContextLogic Announces Adjournment of Annual Meeting of Stockholders to Allow Additional Time for Stockholders to Vote "FOR" the Reorganization ProposalGlobeNewswireApproximately 99% of Shares Voted have been "FOR" the Reorganization Proposal Additional Shares Needed to Vote "FOR" to Approve the Reorganization Urges ALL Stockholders to Protect the Value of their Investment by
1y agoLOGCContextLogic Inc. to Commence Trading on the OTC Markets and Delist from NasdaqGlobeNewswireOAKLAND, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today announced its intention to voluntarily delist from The Nasdaq Global Market at the
1y agoLOGCContextLogic Inc. Reports First-Quarter 2025 Financial ResultsGlobeNewswireOAKLAND, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter ended March 31, 2025.
1y agoLOGCContextLogic to Announce First Quarter 2025 Results on May 9, 2025GlobeNewswireOAKLAND, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic" or the "Company") today announced it will report its first quarter 2025 financial results after the close of market on
1y agoLOGCContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial ResultsGlobeNewswireOAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC) ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and fiscal year ended December 31,
1y agoLOGCContextLogic to Announce Fourth Quarter and Full Year 2024 Results and Provide Strategic Update on March 12, 2025GlobeNewswireOAKLAND, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic," the "Company," "we" or "our") today announced it will report its fourth quarter and full year 2024 financial results
1y agoLOGCContextLogic Announces Up to $150 Million Strategic Investment by BC PartnersGlobeNewswireStrategic investment and capital commitment positions the Company to execute on its stated acquisition-led value maximization strategy; ContextLogic to have up to $300 million of investible cash Ted Goldthorpe, Head
2y agoLOGCContextLogic Inc. Reports Third-Quarter 2024 Financial ResultsGlobeNewswireOAKLAND, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and nine months ended September
2y agoLOGCContextLogic Inc. Reports Second-Quarter Financial ResultsGlobeNewswireOAKLAND, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- ContextLogic Inc. (NASDAQ:LOGC), ("ContextLogic," the "Company," "we" or "our") today reported its financial results for the quarter and six months ended June 30,
3y agoLOGCRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: VisiongainGlobeNewswireAs per the report by Visiongain, the Rare Diseases Market was valued at US$188.58 billion in 2022 and is projected to grow at a CAGR of 12.27% during the forecast period 2023-2033. Visiongain has published a new report
3y agoLOGCRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports LtdGlobeNewswireVisiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic
3y agoLOGCRare Diseases Market is projected to grow at a CAGR of 12.27% by 2033: Visiongain Reports LtdGlobeNewswireVisiongain has published a new report entitled Rare Diseases 2023-2033. It includes profiles of Rare Diseases and Forecasts Market Segment by Diseases (Cancer, Metabolic Diseases, Neurological Conditions, Hematologic
3y agoAZN LOGCAlexion, AstraZeneca Rare Disease, Completes Acquisition of LogicBio® TherapeuticsBusiness WireLogicBio acquisition to build on current collaborations and advancements in genomic medicine Alexion, AstraZeneca Rare Disease, today announced the completion of its acquisition of LogicBio® Therapeutics, Inc.
3y agoLOGCLogicBio Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business UpdatesPR Newswire- Pre-clinical results published in PLOS ONE demonstrating a single intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with prevention of severe weight loss and mortality when challenged with
4y agoAZN CRDF DAWN KTTA+2Central Nervous System Disorders Therapeutics Market Expected to Reach $159 Billion by 2028PR NewswireFinancialNewsMedia.com News Commentary Palm Beach, Fla., Oct. 12, 2022 /PRNewswire/ -- The COVID pandemic has not only had a negative effect on most markets but it has also spurred growth in several worldwide markets.
4y agoOXY COP FANG HAL+19Stocks making the biggest moves midday: Peloton, Tesla, Viasat, Wells Fargo, Box and moreCNBCThese are the stocks posting the largest moves midday.
4y agoAZN LOGCAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicineBusiness WireLogicBio acquisition to build on current collaborations and advancements in genomic medicine Alexion, AstraZeneca Rare Disease, today announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio® Therapeutics, Inc.
4y agoLOGCAlexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic MedicinePR NewswireLogicBio acquisition to build on current collaborations and advancements in genomic medicine LEXINGTON, Mass., Oct. 3, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a pioneering clinical-stage genomic medicine company, today
4y agoLOGCLogicBio® Therapeutics Announces Pre-Clinical Results for mLB-001 Published in Peer-reviewed Journal PLOS ONEPR NewswireSingle intravenous administration of mLB-001 in neonatal or adult MMA mice correlated with prevention of severe weight loss and mortality when challenged with a high protein diet. LEXINGTON, Mass., Sept. 21, 2022 /PRNewswire/ -- LogicBio Therapeutics,
4y agoLOGCLogicBio Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate UpdatePR Newswire- Interim data from SUNRISE trial in four pediatric patients showed detectable levels of ALB-2A biomarker demonstrating site-specific gene insertion and protein expression - Two of four patients demonstrated increasing ALB-2A levels over time, indicati
4y agoLOGCLogicBio® Therapeutics to Present at H.C. Wainwright Global Investment ConferencePR NewswireLEXINGTON, Mass., May 17, 2022 /PRNewswire/ -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview at the H.
4y agoLOGCLogicBio Therapeutics Reports First Quarter 2022 Financial Results and Highlights Recent Business UpdatesPR Newswire–FDA lifted clinical hold on SUNRISE trial in pediatric patients with methylmalonic acidemia –Interim clinical data from Phase 1/2 trial expected to be presented by end of second quarter 2022 –LogicBio to present at ASGCT 2022 Annual Meeting
4y agoLOGCLogicBio Therapeutics Announces Upcoming Presentations on GeneRide Development Candidate and Multiple Advancements in AAV Manufacturing Processes at ASGCT Annual MeetingPR Newswire-GeneRide® LB-401 preclinical data in HT1 demonstrated substantial and durable reduction of disease-related biomarkers -Proprietary AAV transfection process, harnessing mAAVRx™ system, showed 15- to 30-fold yield increase over standard processes -
4y agoLCID LOGC NKLA PRTY+1Thinking about buying stock in LogicBio Therapeutics, Rivian Automotive, Lucid Group, Party City, or Nikola Corp?PR NewswireNEW YORK, May 9, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LOGC, RIVN, LCID, PRTY, and NKLA. To
4y agoLOGCLogicBio Therapeutics Announces FDA Lifts Clinical Hold on SUNRISE Trial in Pediatric Patients with Methylmalonic AcidemiaPR Newswire–Company initiates activities to resume dosing –Interim clinical data from Phase 1/2 trial expected to be presented by end of second quarter 2022 LEXINGTON, Mass., May 9, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clini
4y agoLOGCLogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing ConferencePR NewswireLEXINGTON, Mass., March 23, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will present a company overview at th
4y agoLOGCLogicBio Therapeutics to Present at Barclays Global Healthcare ConferencePR NewswireLEXINGTON, Mass., March 8, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today announced that president and chief executive officer, Frederic Chereau, will participate in a fireside chat du
4y agoLOGCLogicBio Therapeutics Reports Full Year 2021 Financial Results and Provides Business UpdatesPR NewswireLEXINGTON, Mass., March 4, 2022 /PRNewswire/ -- LogicBio® Therapeutics, Inc. (NASDAQ:LOGC), a clinical-stage genetic medicine company, today reported financial results for the year ended December 31, 2021, and provided business updates.